Does BEVACIZUMAB Cause Decreased appetite? 2,559 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,559 reports of Decreased appetite have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 3.3% of all adverse event reports for BEVACIZUMAB.
2,559
Reports of Decreased appetite with BEVACIZUMAB
3.3%
of all BEVACIZUMAB reports
682
Deaths
944
Hospitalizations
How Dangerous Is Decreased appetite From BEVACIZUMAB?
Of the 2,559 reports, 682 (26.7%) resulted in death, 944 (36.9%) required hospitalization, and 76 (3.0%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for BEVACIZUMAB.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which BEVACIZUMAB Alternatives Have Lower Decreased appetite Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ